1. Home
  2. HNI vs XENE Comparison

HNI vs XENE Comparison

Compare HNI & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HNI Corporation

HNI

HNI Corporation

HOLD

Current Price

$48.05

Market Cap

3.4B

ML Signal

HOLD

Logo Xenon Pharmaceuticals Inc.

XENE

Xenon Pharmaceuticals Inc.

SELL

Current Price

$36.34

Market Cap

3.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HNI
XENE
Founded
1944
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
HNI
XENE
Price
$48.05
$36.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
19
Target Price
$71.00
★ $72.43
AVG Volume (30 Days)
453.7K
★ 1.8M
Earning Date
11-03-2026
11-02-2026
Dividend Yield
★ 3.11%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.17
N/A
Revenue
★ $2,839,000,000.00
$311,000.00
Revenue This Year
$110.77
N/A
Revenue Next Year
$3.54
$2,045.70
P/E Ratio
$266.35
★ N/A
Revenue Growth
★ 12.37
N/A
52 Week Low
$28.93
$33.38
52 Week High
$52.79
$72.66

Technical Indicators

Market Signals
Indicator
HNI
XENE
Relative Strength Index (RSI) 55.11 35.58
Support Level $46.92 N/A
Resistance Level $48.24 $39.92
Average True Range (ATR) 1.43 1.23
MACD -0.02 0.91
Stochastic Oscillator 77.59 59.44

Price Performance

Historical Comparison
HNI
XENE

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: